301201 Chengda Pharmaceuticals
- 21.73
- +0.03+0.14%
Chengda Pharmaceuticals News
Chengda Pharmaceutical: Announcement on providing guarantees for wholly-owned Sun Company to apply for loans from banks
Chengda Pharmaceutical: Announcement of Resolutions of the 10th Meeting of the Fifth Board of Supervisors
Chengda Pharmaceutical: Announcement of Resolutions of the 10th Meeting of the Fifth Board of Directors
Chengda Pharmaceutical: 301201 Chengda Pharmaceutical Research Activity Information 20241023
Chengda Pharmaceutical: 301201 Chengda Pharmaceutical Research Activity Information 20240929
Chengda Pharmaceutical: 301201 Chengda Pharmaceutical Research Activity Information 20240926
Chengda Pharmaceutical: Everbright Securities Co., Ltd.\'s 2024 semi-annual follow-up report on Chengda Pharmaceutical Co., Ltd.
Chengda Pharmaceutical: Announcement of Board Resolutions
Chengda Pharmaceutical: Announcement of Supervisory Committee Resolutions
Chengda Pharmaceutical: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Chengda Pharmaceuticals: Announcement of the resolution of the 8th meeting of the 5th board of directors.
Chengda Pharmaceuticals: Everbright Securities Co. Ltd.'s audit opinion on the extension of the implementation period of certain raised funds investment projects of Chengda Pharmaceutical Co., Ltd.
Chengda Pharmaceuticals: Announcement of the resolution of the eighth meeting of the fifth board of supervisors.
Chengda Pharmaceuticals: 301201 Chengda Pharmaceutical Research Activity Information 20240524
Chengda Pharmaceuticals: 301201 Chengda Pharmaceutical 2023 Annual Results Briefing 20240510
Chengda Pharmaceuticals: Everbright Securities Co., Ltd.'s 2023 Annual Follow-up Report on Chengda Pharmaceutical Co., Ltd.
Chengda Pharmaceuticals: Announcement on holding the 2023 Annual Results Briefing
Chengda Pharmaceutical: Fund Raising Management System
Chengda Pharmaceutical: 2023 Independent Director Debriefing Report (Wang Ping)
Chengda Pharmaceutical: 2023 Annual Audit Report
Analysis
Price Target
No Data
No Data